March is Kidney Cancer Awareness Month

In this slide show, we feature various images of papillary, clear cell, chromophobe, and tubulocystic renal cell carcinoma.

Recent Content

For women at risk for an inherited type of breast cancer, the decision to be tested for specific genes and make preventative decisions can be life-changing.

Through whole-exome sequencing, researchers for the first time have identified a link between a mutation in PARK2, a gene associated with early-onset Parkinson's disease and familial lung cancer.

New data are suggesting that the loss of two genes, MAP3K7 and CHD1, may be a unique driver of aggressive prostate cancer development.

Clinicians in the not too distant future may have a new tool for treating bladder cancer. The US Food and Drug Administration (FDA) on March 9, 2015, granted fast track designation for HS-410 (vesigenurtacel-L) for the treatment of non-muscle invasive bladder cancer (NMIBC).

While the pooled data on those who take aspirin regularly suggest its use lowers the risk of colorectal cancer, the effect varies for each individual, depending on genetic variations.

A 22-year-old man presents with enlarged axillary lymph nodes. What is your diagnosis?

Targeted treatments for triple-negative breast cancers--which test negative for estrogen (ER), progesterone (PR), and HER2 receptors--have been nonexistent outside of clinical trials. The problem being, without a hormonal target or genetic driver, drug development for this cancer population is challenging--until now.

By clicking Accept, you agree to become a member of the UBM Medica Community.